CARY STREET PARTNERS INVESTMENT ADVISORY LLC
Position in MRK — Merck & Co., Inc.
CIK 1766904
RICHMOND, VA
Position in MRK
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,041,359
+$201,261 QoQ
Shares Held
8,104
+16.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#2,085
of 3,769 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARY STREET PARTNERS INVESTMENT ADVISORY LLC holds $10,872,180 across 13 Drug Manufacturers - General names. MRK ranks #4 (9.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,853 | $3,421,967 | |
| 2 | ABBV |
AbbVie Inc.
|
9,052 | $2,277,835 | |
| 3 | JNJ |
Johnson & Johnson
|
5,727 | $1,454,479 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
8,104 | $1,041,359 | |
| 5 | AMGN |
Amgen Inc
|
2,175 | $787,606 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,702 | $467,705 | |
| 7 | NVS |
Novartis AG
|
2,406 | $377,067 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
6,072 | $349,863 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,041,359 | 8,104 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $840,098 | 6,984 | Shares | Other | 2026-04-29 | |
| 2025-12-31 | $634,398 | 6,027 | Shares | Other | 2026-02-09 | |
| 2025-09-30 | $418,218 | 4,983 | Shares | Other | 2025-11-10 | |
| 2025-06-30 | $375,055 | 4,738 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $512,705 | 5,712 | Shares | Other | 2025-05-09 | |
| 2024-12-31 | $609,210 | 6,124 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $21,004,620 | 184,965 | Shares | Defined | 2024-10-30 | |
| 2024-06-30 | $22,236,706 | 179,618 | Shares | Other | 2024-07-22 | |
| 2024-03-31 | $23,680,797 | 179,468 | Shares | Defined | 2024-04-30 | |
| 2023-12-31 | $19,549,789 | 179,323 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $18,443,283 | 179,148 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $13,446,050 | 116,527 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $12,058,987 | 113,347 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $12,760,359 | 115,010 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,081,982 | 117,069 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,843,716 | 107,971 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $3,228,913 | 39,353 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,026,283 | 39,487 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,655,514 | 35,355 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $2,834,872 | 36,452 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,843,916 | 23,919 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,738,267 | 70,150 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $9,280,035 | 111,875 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||